Lebwohl, Mark

Secukinumab in plaque psoriasis—results of two phase 3 trials

Langley, R. G., Elewski, B. E., Lebwohl, M., Reich, K., Griffiths, C. E. M., Papp, K., Puig, L., Nakagawa, H., Spelman, L., Sigurgeirsson, B., et al. (2014) · New England Journal of Medicine

Psoriasis: Treatment and PathogenesisDermatology and Skin Diseases

Cited by 1,997

Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials

Griffiths, C. E. M., Reich, K., Lebwohl, M., van de Kerkhof, P., Paul, C., Menter, A., Cameron, G. S., Erickson, J., Zhang, L., Secrest, R. J., et al. (2015) · The Lancet

Psoriasis: Treatment and PathogenesisDermatology and Skin Diseases

Cited by 834

Efficacy and safety of fezakinumab (an IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments: A randomized, double-blind, phase 2a trial

Guttman-Yassky, E., Brunner, P. M., Neumann, A. U., Khattri, S., Pavel, A. B., Malik, K., Singer, G. K., Baum, D., Gilleaudeau, P., Sullivan-Whalen, M., et al. (2018) · Journal of the American Academy of Dermatology

Dermatology and Skin DiseasesPsoriasis: Treatment and Pathogenesis

Cited by 343

Identification of Possible Reactive Oxygen Species Involved in Ultraviolet Radiation-Induced Oxidative DNA Damage

Zhang, X., Rosenstein, B. S., Wang, Y., Lebwohl, M., & Wei, H. (1997) · Free Radical Biology and Medicine

Carcinogens and Genotoxicity AssessmentDNA Repair Mechanisms

Cited by 216

Psychiatric adverse events during treatment with brodalumab: Analysis of psoriasis clinical trials

Lebwohl, M. G., Papp, K. A., Marangell, L. B., Koo, J., Blauvelt, A., Gooderham, M., Wu, J. J., Rastogi, S., Harris, S., Pillai, R., et al. (2018) · Journal of the American Academy of Dermatology

Psoriasis: Treatment and PathogenesisDermatology and Skin Diseases

Cited by 179

Induction of 8‐Oxo‐7,8‐Dihydro‐2'‐Deoxyguanosine by Ultraviolet Radiation in Calf Thymus DNA and HeLa Cells

Zhang, X., Rosenstein, B. S., Wang, Y., Lebwohl, M., Mitchell, D. M., & Wei, H. (1997) · Photochemistry and Photobiology

DNA Repair MechanismsCarcinogens and Genotoxicity Assessment

Cited by 129

Photoprotective effect of isoflavone genistein on ultraviolet B-induced pyrimidine dimer formation and PCNA expression in human reconstituted skin and its implications in dermatology and prevention of cutaneous carcinogenesis

Moore, J. O., Wang, Y., Stebbins, W. G., Gao, D., Zhou, X., Phelps, R., Lebwohl, M., & Wei, H. (2006) · Carcinogenesis

Skin Protection and AgingCarcinogens and Genotoxicity Assessment

Cited by 122

Combined subcarcinogenic benzo[a]pyrene and UVA synergistically caused high tumor incidence and mutations in H‐ras gene, but not p53, in SKH‐1 hairless mouse skin

Wang, Y., Gao, D., Atencio, D. P., Perez, E., Saladi, R., Moore, J., Guevara, D., Rosenstein, B. S., Lebwohl, M., & Wei, H. (2005) · International Journal of Cancer

Carcinogens and Genotoxicity AssessmentSkin Protection and Aging

Cited by 35

Two-year US Pharmacovigilance report on Brodalumab

Lebwohl, M., Leonardi, C., Wu, J. J., Armstrong, A., Rawnsley, N., Merchant, M., Alexander, B., & Jacobson, A. (2021) · Dermatology and Therapy

Psoriasis: Treatment and PathogenesisPharmacovigilance and Adverse Drug Reactions

Cited by 24